Interferon in the management of chronic hepatitis B. (Q40891677)

24 September 2017

1 reference

title

Interferon in the management of chronic hepatitis B. (English)

1 reference

24 September 2017

R P Perrillo

1

1 reference

24 September 2017

1 April 1993

1 reference

Digestive Diseases and Sciences

24 September 2017

1 reference

24 September 2017

38

1 reference

24 September 2017

4

1 reference

24 September 2017

577-593

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01316785

24 September 2017

0 references

cites work

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Experience with interferon in chronic hepatitis B in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Diabetes mellitus and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Inhibition of antipyrine metabolism by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01316785

Interferons, a group of multiple lymphokines

21 January 2018

1 reference

12 December 2020

Corticosteroid therapy for chronic active hepatitis B: is a little to much?

1 reference

12 December 2020

Psychiatric complications of long-term interferon alfa therapy.

1 reference

12 December 2020

Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B

1 reference

12 December 2020

Autoimmune thyroid disease in interferon-treated patients

1 reference

12 December 2020

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

12 December 2020

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis

1 reference

12 December 2020

Familial Clustering of Hepatitis B Infection

1 reference

12 December 2020

Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon

1 reference

12 December 2020

Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver

1 reference

12 December 2020

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

12 December 2020

Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage

1 reference

12 December 2020

Histological improvement after anti-viral treatment for chronic hepatitis B virus infection

1 reference

12 December 2020

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

12 December 2020

Immunological aspects of antiviral therapy

1 reference

12 December 2020

Hepatitis B: Evolving Epidemiology and Implications for Control

1 reference

12 December 2020

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B

1 reference

12 December 2020

Natural history of hepatitis-associated antigen-positive chronic liver disease

1 reference

12 December 2020

Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

1 reference

12 December 2020

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

12 December 2020

Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state

1 reference

12 December 2020

Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease

1 reference

12 December 2020

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

12 December 2020

Side effects of alpha interferon

1 reference

12 December 2020

The interferon system in acute and chronic viral hepatitis

1 reference

12 December 2020

Immunization policies and vaccine coverage among adults. The risk for missed opportunities

1 reference

12 December 2020

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

12 December 2020

Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro

1 reference

12 December 2020

Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis

1 reference

12 December 2020

Spontaneous reactivation of chronic hepatitis B virus infection.

1 reference

12 December 2020

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.

1 reference

12 December 2020

Natural history of chronic type B hepatitis

1 reference

12 December 2020

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection

1 reference

12 December 2020

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

12 December 2020

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

12 December 2020

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

12 December 2020

Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis

1 reference

12 December 2020

Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection

1 reference

12 December 2020

Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy

1 reference

12 December 2020

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

12 December 2020

Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study

1 reference

12 December 2020

Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

12 December 2020

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus

1 reference

12 December 2020

Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis

1 reference

12 December 2020

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

12 December 2020

Treatment of chronic hepatitis B with interferon: experience in western countries

1 reference

12 December 2020

Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis

1 reference

12 December 2020

Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen

1 reference

12 December 2020

Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up

1 reference

12 December 2020

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

1 reference

12 December 2020

Alpha-interferon treatment in Chinese patients with chronic hepatitis B.

1 reference

12 December 2020

Immunology and the liver

1 reference

12 December 2020

Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon

1 reference

12 December 2020

Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection

1 reference

12 December 2020

Inhibition of theophylline metabolism by interferon

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

Liver transplantation for viral hepatitis

1 reference

12 December 2020

HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis

1 reference

12 December 2020

Interferon in viral hepatitis: role in pathogenesis and treatment

1 reference

12 December 2020

1 reference

12 December 2020

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

12 December 2020

Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B

1 reference

12 December 2020

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

1 reference

12 December 2020

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

1 reference

12 December 2020

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

12 December 2020

NIH conference. Hepatocellular carcinoma

1 reference

12 December 2020

Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection

1 reference

12 December 2020

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

12 December 2020

Chronic type B hepatitis and the "healthy" HBsAg carrier state

1 reference

12 December 2020

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

12 December 2020

A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis

1 reference

12 December 2020

The mode of action of interferons in viral infections and their possible role in the control of hepatitis B.

1 reference

12 December 2020

Treatment of chronic hepatitis B with interferon alfa-2b

1 reference

12 December 2020

Prevention and Therapy of Viral Hepatitis

1 reference

12 December 2020

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease

1 reference

12 December 2020

Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection

1 reference

12 December 2020

Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes

1 reference

12 December 2020

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

12 December 2020

Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen

1 reference

12 December 2020

Mechanisms of action of interferons

1 reference

12 December 2020

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

12 December 2020

Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon

1 reference

12 December 2020

Steroids in chronic B-hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. A trial group of the European Association for the Study of the Liver

1 reference

12 December 2020

Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01316785

1 reference

24 September 2017

1 reference

PubMed ID

8462360